McMurray JS - Search Results

1

Notch activation inhibits AML growth and survival: a potential therapeutic approach.

Kannan S, Sutphin RM, Hall MG, Golfman LS, Fang W, Nolo RM, Akers LJ, Hammitt RA, McMurray JS, Kornblau SM, Melnick AM, Figueroa ME, Zweidler-McKay PA. Kannan S, et al. Among authors: mcmurray js. J Exp Med. 2013 Feb 11;210(2):321-37. doi: 10.1084/jem.20121527. Epub 2013 Jan 28. J Exp Med. 2013. PMID: 23359069 Free PMC article.

2

Notch/HES1-mediated PARP1 activation: a cell type-specific mechanism for tumor suppression.

Kannan S, Fang W, Song G, Mullighan CG, Hammitt R, McMurray J, Zweidler-McKay PA. Kannan S, et al. Blood. 2011 Mar 10;117(10):2891-900. doi: 10.1182/blood-2009-12-253419. Epub 2011 Jan 11. Blood. 2011. PMID: 21224467 Free PMC article.

3

Biochemical and Cellular Specificity of Peptide Inhibitors of G Protein-Coupled Receptor Kinases.

Baameur F, Hammitt RA, Friedman J, McMurray JS, Clark RB. Baameur F, et al. Among authors: mcmurray js. Int J Pept Res Ther. 2014 Mar;20(1):1-12. doi: 10.1007/s10989-013-9357-9. Int J Pept Res Ther. 2014. PMID: 25530741 Free PMC article.

4

Role for the regulator of G-protein signaling homology domain of G protein-coupled receptor kinases 5 and 6 in beta 2-adrenergic receptor and rhodopsin phosphorylation.

Baameur F, Morgan DH, Yao H, Tran TM, Hammitt RA, Sabui S, McMurray JS, Lichtarge O, Clark RB. Baameur F, et al. Among authors: mcmurray js. Mol Pharmacol. 2010 Mar;77(3):405-15. doi: 10.1124/mol.109.058115. Epub 2009 Dec 28. Mol Pharmacol. 2010. PMID: 20038610 Free PMC article.

5

A phosphopeptide mimetic prodrug targeting the SH2 domain of Stat3 inhibits tumor growth and angiogenesis.

Auzenne EJ, Klostergaard J, Mandal PK, Liao WS, Lu Z, Gao F, Bast RC Jr, Robertson FM, McMurray JS. Auzenne EJ, et al. Among authors: mcmurray js. J Exp Ther Oncol. 2012;10(2):155-62. J Exp Ther Oncol. 2012. PMID: 23350355 Free PMC article.

6

Model of intermolecular interactions between high affinity phosphopeptides and Stat3.

McMurray JS, Ren Z, Mandal PK, Chen X. McMurray JS, et al. Adv Exp Med Biol. 2009;611:543-4. doi: 10.1007/978-0-387-73657-0_238. Adv Exp Med Biol. 2009. PMID: 19400305 No abstract available.

7

Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells.

Robertson FM, Simeone AM, Mazumdar A, Shah AH, McMurray JS, Ghosh S, Cristofanilli M. Robertson FM, et al. Among authors: mcmurray js. J Exp Ther Oncol. 2008;7(4):299-312. J Exp Ther Oncol. 2008. PMID: 19227010

8

Inhibition of Stat3 by cell-permeable peptidomimetic prodrugs targeted to its SH2 domain.

McMurray JS, Mandal PK, Liao WS, Ren Z, Chen X. McMurray JS, et al. Adv Exp Med Biol. 2009;611:545-6. doi: 10.1007/978-0-387-73657-0_239. Adv Exp Med Biol. 2009. PMID: 19400306 No abstract available.

9

Interferon γ is a STAT1-dependent direct inducer of BCL6 expression in imatinib-treated chronic myeloid leukemia cells.

Madapura HS, Nagy N, Ujvari D, Kallas T, Kröhnke MCL, Amu S, Björkholm M, Stenke L, Mandal PK, McMurray JS, Keszei M, Westerberg LS, Cheng H, Xue F, Klein G, Klein E, Salamon D. Madapura HS, et al. Among authors: mcmurray js. Oncogene. 2017 Aug 10;36(32):4619-4628. doi: 10.1038/onc.2017.85. Epub 2017 Apr 3. Oncogene. 2017. PMID: 28368400

10

Application of triethylsilane and palladium-charcoal-induced reductions in the synthesis of Fmoc-glutamic acid analogues.

Mandal PK, McMurray JS. Mandal PK, et al. Among authors: mcmurray js. Adv Exp Med Biol. 2009;611:181-2. doi: 10.1007/978-0-387-73657-0_83. Adv Exp Med Biol. 2009. PMID: 19400150 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters